33704-19-7 Usage
Uses
Used in Pharmaceutical Synthesis:
3-(TERT-BUTOXYCARBONYL)BENZOICACID is used as a protecting group for amines in the synthesis of pharmaceuticals. The Boc group temporarily protects the amino group, enabling selective reactions at other functional groups without affecting the amine. This selective protection is crucial for the synthesis of complex pharmaceutical molecules with specific properties and therapeutic effects.
Used in Agrochemical Production:
3-(TERT-BUTOXYCARBONYL)BENZOICACID is also used as a building block in the production of agrochemicals. Its versatility and reactivity allow for the synthesis of complex agrochemical molecules with desired properties, such as pest control, herbicidal, or fungicidal activities. The benzoic acid moiety provides additional functionality for further chemical modifications or reactions, enhancing the effectiveness and selectivity of the resulting agrochemicals.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(TERT-BUTOXYCARBONYL)BENZOICACID is employed as a versatile intermediate for the synthesis of various organic compounds. The Boc group allows for selective reactions at other functional groups, while the benzoic acid moiety offers additional points for further chemical modifications. This dual functionality makes 3-(TERT-BUTOXYCARBONYL)BENZOICACID a valuable building block for the development of new organic compounds with potential applications in various industries, such as materials science, pharmaceuticals, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 33704-19-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,7,0 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 33704-19:
(7*3)+(6*3)+(5*7)+(4*0)+(3*4)+(2*1)+(1*9)=97
97 % 10 = 7
So 33704-19-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H14O4/c1-12(2,3)16-11(15)9-6-4-5-8(7-9)10(13)14/h4-7H,1-3H3,(H,13,14)
33704-19-7Relevant academic research and scientific papers
FARNESOID X RECEPTOR AGONISTS
-
Page/Page column 115, (2009/03/07)
The present invention relates to famesoid X receptors (FXR, NR1H4) FXR is a member of the nuclear receptor class of ligand-activate transcription factors More particularly, the present invention relates to compounds useful as agonists for FXR, pharmaceutical formulations comprising such compounds, and therapeutic use of the same Novel isoxazole compounds are disclosed as part of pharmaceutical compositions for the treatment of a condition mediated by decreased FXR activity, such as obesity, diabetes, cholestatic liver disease, liver fibrosis, and metabolic syndrome
